FP7 to strengthen support for pan-European research infrastructures

EU Science and Research Commissioner Janez Potocnik has provided details of how the Seventh Framework Programme (FP7) will continue to support the development of integrated research infrastructures of pan European interest.

Speaking to an audience at the German Science Council in Mainz on 7 July, Mr Potocnik said that researchers were increasingly finding it difficult to complete their research projects within the confines of their own laboratories.

"In many cases, for the most ambitious projects, they need to rely upon the services of a larger research facility. Accessing research facilities in a foreign country has in the past often been associated with more or less administrative and financial burden," he said.

Reacting to this situation, the European Commission has developed a number of initiatives within the Framework Programme (FP) to help researchers overcome these difficulties. They include the financing of 'Transnational Access', which fund access to major research infrastructures actions for research teams. This will continue under FP7, assured the Commissioner.

With the start of Sixth Framework Programme (FP6), the Commission went even further, noted Mr Potocnik, introducing 'Integrated Infrastructure Initiatives', through which Research Infrastructures (RIs) can coordinate their services and their development to fit better the needs of the scientific community. This programme combines, within a single contract, networking activities (including consortium management); provision of access to transnational users; and joint research activities.

Key to the development of RIs is the work undertaken by the European Strategy Forum for Research Infrastructures (ESFRI). Established in 2002, the Forum brings together representatives of EU Member States and Associated States, as well as the Commission, to support a coherent approach to policy-making on research infrastructures in Europe, and to act as an incubator for international negotiations on concrete initiatives.

Together with the Commission, ESFRI is set to produce the first roadmap for new infrastructures. To be launched in the autumn, the roadmap will identify new infrastructures of pan-European interest (or major upgrades) corresponding to needs of the European research communities, covering all scientific areas, regardless of possible location.

"It will therefore be a useful tool for every policy maker in Europe in offering numerous options for research investment," said the Commissioner.

In a recent review of its national research projects, the German Science Council concluded that several projects were of such a dimension and scientific aspiration that they would be better pursued jointly at international level. These included the Facility for Antiproton and Ion Research (FAIR) and the X-Ray Free Electron Laser (XFEL). Furthermore, The Council also recommended that research vessel Aurora Borealis be realised as a joint European effort.

"This makes these project natural candidates for the European Roadmap. The Commission intends to use the ESFRI list of projects for focusing its support activities for new construction projects under FP7," said Mr Potocnik.

He went on to note that in FP7, the Commission will expand its support to international consortia, which will eventually result in facilities built on a joint basis. "The Commission has indeed the capability to play a catalysing role in the negotiations for intergovernmental agreements," said the Commissioner.

Regarding construction of such facilities, Mr Potocnik suggested that Community support could take the form of sharing some of the construction costs, as well facilitating loans through the new Risk Sharing Finance Facility. "This facility offers the promise to start a new era, not only with much easier access to research funds, but also for managing differently research projects," concluded Mr Potocnik.

For more information on the ESFRI, please visit:
http://cordis.europa.eu/esfri/home.html

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...